Drug
V0162
V0162: highest development phase Phase 2, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| V0162 NCT01951222 | Phase 2 | Asthma |
Latest
No recent events.
Follow V0162 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.